1 Day SNDA -0.26% DJIA 0.65% Russell 2K -1.03% Health Care/Life Sciences -1.12% ...

Merck MRK announced that the FDA has accepted its supplemental new drug application (sNDA) seeking approval of its oral HIF-2α inhibitor, Welireg (belzutifan), for a new indication. The sNDA is ...

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience. To access our Live RNS you must confirm you are a private ...

Buy SNDA near 20.28 target 26.36 stop loss @ 20.22 Details The technical summary data tells us to buy SNDA near 20.28 with an upside target of 26.36. This data also tells us to set a stop loss @ 20.22 ...

The US Food and Drug Administration (FDA) has accepted for priority review a supplemental new drug application (sNDA) for Welireg (belzutifan ... or a flexible monthly subscription The Pharma Letter ...

Outgoing presidents traditionally leave a letter for the incoming president. Former President Joe Biden wished President Donald Trump "all the best for the next four years" in the letter he left ...

Jan 21 (Reuters) - U.S. President Donald Trump on Tuesday said former President Joe Biden left him a "nice" letter inside the Resolute Desk at the White House, continuing an inauguration day ...

WASHINGTON − Former President Joe Biden left a letter for the man replacing him in the Oval Office, continuing a tradition dating back 36 years. President Donald Trump discovered the letter ...

Johnson & Johnson announced the U.S. FDA approval of a supplemental New Drug Application for Spravato CIII nasal spray, making this innovative treatment the first and only monotherapy for adults ...

Scilex (SCLX) announced that it will be filing today of a Supplemental New Drug Application, SNDA, with the FDA for ELYXYB in acute pain indication. “We are well positioned to broaden the ELYXYB ...